Last update 10 May 2025

BLS-ILB-MD1

Overview

Basic Info

Drug Type
Therapeutic vaccine, Genetically engineered subunit vaccine
Synonyms
BLS M22, BLS-M22, BLS-MX022
+ [1]
Target
MSTN
Action
inhibitors
Mechanism
MSTN inhibitors(Growth/differentiation factor 8 inhibitors)
Therapeutic Areas
Nervous System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases+ [1]
Active Indication-
Inactive Indication
Muscular Dystrophy, Duchenne
Originator Organization
MOA Life Plus Co., Ltd.MOA Life Plus Co., Ltd.
Active Organization-
Inactive Organization
MOA Life Plus Co., Ltd.MOA Life Plus Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with BLS-ILB-MD1
NCT03789734
/ CompletedPhase 1
A Dose Block-randomized, Double-blind, Placebo-controlled and Dose-escalation Phase I Clinical Trial to Evaluate Safety of BLS-M22 Following Single/Multiple Oral Administration in Healthy Adult Volunteers
100 Clinical Results associated with BLS-ILB-MD1
Login to view more data
100 Translational Medicine associated with BLS-ILB-MD1
Login to view more data
100 Patents (Medical) associated with BLS-ILB-MD1
Login to view more data
100 Deals associated with BLS-ILB-MD1
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Muscular Dystrophy, DuchennePhase 1
United States
MOA Life Plus Co., Ltd.MOA Life Plus Co., Ltd.
04 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free